U.S. Capital Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Buy |
1,779
+95
| +6% | +$38.5K | 0.02% | 508 |
|
|
2025
Q1 | $838K | Sell |
1,684
-33
| -2% | -$16.4K | 0.03% | 460 |
|
|
2024
Q4 | $893K | Buy |
1,717
+26
| +2% | +$13.5K | 0.03% | 444 |
|
|
2024
Q3 | $1.05M | Sell |
1,691
-119
| -7% | -$73.6K | 0.04% | 349 |
|
|
2024
Q2 | $1M | Sell |
1,810
-177
| -9% | -$97.9K | 0.04% | 345 |
|
|
2024
Q1 | $1.15M | Sell |
1,987
-4,960
| -71% | -$2.88M | 0.04% | 321 |
|
|
2023
Q4 | $3.69M | Sell |
6,947
-1,659
| -19% | -$881K | 0.15% | 147 |
|
|
2023
Q3 | $4.36M | Buy |
8,606
+175
| +2% | +$88.6K | 0.2% | 113 |
|
|
2023
Q2 | $4.4M | Buy |
8,431
+119
| +1% | +$62.1K | 0.21% | 112 |
|
|
2023
Q1 | $4.79M | Sell |
8,312
-548
| -6% | -$316K | 0.22% | 105 |
|
|
2022
Q4 | $4.88M | Buy |
8,860
+602
| +7% | +$332K | 0.23% | 99 |
|
|
2022
Q3 | $4.19M | Buy |
8,258
+67
| +0.8% | +$34K | 0.21% | 105 |
|
|
2022
Q2 | $4.45M | Sell |
8,191
-1,497
| -15% | -$813K | 0.2% | 108 |
|
|
2022
Q1 | $5.72M | Sell |
9,688
-231
| -2% | -$136K | 0.21% | 103 |
|
|
2021
Q4 | $6.62M | Buy |
9,919
+56
| +0.6% | +$37.4K | 0.26% | 87 |
|
|
2021
Q3 | $5.64M | Buy |
+9,863
| New | +$5.64M | 0.24% | 100 |
|